Home Infusion Therapy Market Size Worth $41.6 Billion By 2027

February 2020 | Report Format: Electronic (PDF)

The global home infusion therapy market size is expected to reach USD 41.6 billion by 2027, according to a new report by Grand View Research, Inc., registering a CAGR of 7.3% over the forecast period. Increasing incidences of hospital-acquired infections are some of the major factors contributing to the market growth. Home infusion therapy is considered an alternative to an extended stay in hospitals or nursing homes for patients suffering from chronic diseases. With the administration of medications in home settings, patients recover faster when compared to the hospital and are more comfortable at home.

Several government and non-government programs are carried out in order to spread awareness among people regarding home infusion therapy. In October 2019, the Centers for Medicare & Medicaid Services issued a rule stating that all home infusion therapy payments will get covered under the Bipartisan Budget Act of 2018. In addition, favorable government policies and regulations are expected to propel the market growth. In February 2018, the Bipartisan Budget Act of 2018 was signed into a law which states that all temporary payments of home infusion therapy in U.S. will be covered by the government in accordance with this regulation.

In addition, the rising prevalence of chronic diseases, such as cardiovascular diseases (CVDs), cancer, diabetes, and other life-threatening conditions, is expected to have a high impact on market growth. According to a WHO report, the above-mentioned diseases accounted for 60.0% of the total deaths and 43.0% of the disease burden in U.S. in 2019. This creates the need to infuse nutritional products that contain glutamine, phospholipids, glucose, and amino acids while administering medication to patients, which, in turn, is expected to boost the market growth in this region.

Technological developments in home infusion therapy devices are also anticipated to make therapy more convenient and user-friendly for patients. For instance, in April 2017, B. Braun launched Easypump home infusion therapy app for both patients and the physician. This app will help patients to safely administer the medicine as per the requirements.

 To request a sample copy or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/home-infusion-therapy-market

Further key findings from the report suggest:

  • Infusion pumps emerged as the largest product segment in 2019 owing to increasing use of delivery fluids such as nutrients and medications

  • The needleless connectors segment is projected to register the highest CAGR over the forecast period as they offer advantages such as improved safety      

  • The anti-infective segment dominated the home infusion therapy market in 2019, as a large number of procedures are performed during the administration of medication such as antibiotics and antifungals

  • North America dominated the global market in 2019. With the increasing demand for new technologies, along with advanced healthcare infrastructure, North America is expected to continue to dominate the market through the forecast period

  • The Asia Pacific market is projected to witness the fastest growth over the forecast period owing to the increasing number of diabetic patients in the region

  • Key market players include B. Braun Melsungen AG; Baxter; Caesarea Medical Electronics; CareFusion Corporation; Fresenius Kabi; ICU Medical, Inc.; JMS Co. Ltd.; Smiths Medical, Inc.; and Terumo Corporation.

Grand View Research has segmented the global home infusion therapy market on the basis of product, application, and region:

Home Infusion Therapy Product Outlook (Revenue, USD Million, 2016 - 2027)

  • Infusion Pumps

    • Ambulatory Infusion Pumps

    • Insulin Pumps

    • Syringe Pumps

    • Elastomeric Pumps

    • Patient Controlled Analgesics (PCA)

    • Volumetric Pumps

  • Intravenous Sets

  • IV Cannulas

  • Needleless Connectors

Home Infusion Therapy Application Outlook (Revenue, USD Million, 2016 - 2027)

  • Anti-Infective

  • Endocrinology

    • Diabetes

    • Others

  • Hydration Therapy

    • Athletes

    • Others

  • Chemotherapy

  • Enteral Nutrition

  • Parenteral Nutrition

  • Specialty Pharmaceuticals

  • Others

Home Infusion Therapy Regional Outlook (Revenue, USD Million, 2016 - 2027)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Spain

    • Italy

    • Netherlands

    • Belgium

    • Switzerland

    • Russia

    • Sweden

  • Asia Pacific

    • India

    • Japan

    • China

    • Australia

    • South Korea

    • Malaysia

    • Indonesia

    • Singapore

    • Philippines

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

    • Chile

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Israel

    • Egypt

Request Sample
Request for Customization

Choose License Type

Single User - $5,950
Multi User (2-5) - $6,950
Enterprise Access - $8,950

Buy Chapters or Sections

Avail customized purchase options to meet your research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

  • Research support

    24/5 Research support

    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Custom research service

    Custom research service

    Speak to the report author to design an exclusive study to serve your research needs.

  • Quality assurance

    Quality assurance

    A testimonial for service excellence represented in the form of BBB "A" Accreditation.

  • BBB Rating dandb
  • Information security

    Information security

    Your personal and confidential information is safe and secure.

  • BOA